Epitomee Medical (Israel) Performance
| EPIT Stock | 929.20 17.20 1.82% |
Epitomee Medical holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.1, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Epitomee Medical will likely underperform. Use Epitomee Medical downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to analyze future returns on Epitomee Medical.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Epitomee Medical are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Epitomee Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Epitomee |
Epitomee Medical Relative Risk vs. Return Landscape
If you would invest 33,250 in Epitomee Medical on August 29, 2024 and sell it today you would earn a total of 59,670 from holding Epitomee Medical or generate 179.46% return on investment over 90 days. Epitomee Medical is generating 5.3802% of daily returns and assumes 38.2637% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Epitomee on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Epitomee Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Epitomee Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Epitomee Medical, and traders can use it to determine the average amount a Epitomee Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1406
| Best Portfolio | Best Equity | EPIT | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 38.26 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Epitomee Medical is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Epitomee Medical by adding it to a well-diversified portfolio.
Epitomee Medical Fundamentals Growth
Epitomee Stock prices reflect investors' perceptions of the future prospects and financial health of Epitomee Medical, and Epitomee Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Epitomee Stock performance.
| Current Valuation | 339.18 M | |||
| Shares Outstanding | 29.58 M | |||
| Price To Book | 3.48 X | |||
About Epitomee Medical Performance
By analyzing Epitomee Medical's fundamental ratios, stakeholders can gain valuable insights into Epitomee Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Epitomee Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Epitomee Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Epitomee Medical performance evaluation
Checking the ongoing alerts about Epitomee Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Epitomee Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Epitomee Medical is way too risky over 90 days horizon | |
| Epitomee Medical appears to be risky and price may revert if volatility continues | |
| About 57.0% of the company shares are held by company insiders |
- Analyzing Epitomee Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Epitomee Medical's stock is overvalued or undervalued compared to its peers.
- Examining Epitomee Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Epitomee Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Epitomee Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Epitomee Medical's stock. These opinions can provide insight into Epitomee Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Epitomee Stock analysis
When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |